Letters to the Editor
Multiresistant organisms at the front line
- Shahriar Sanati, Associate Professor Michael McCullough
- Aust Prescr 2010;33:68-71
- 1 December 2010
- DOI: 10.18773/austprescr.2010.078
The Editorial Executive Committee welcomes letters, which should be less than 250 words. Before a decision to publish is made, letters which refer to a published article may be sent to the author for a response. Any letter may be sent to an expert for comment. When letters are published, they are usually accompanied in the same issue by their responses or comments. The Committee screens out discourteous, inaccurate or libellous statements. The letters are sub-edited before publication. Authors are required to declare any conflicts of interest. The Committee's decision on publication is final.
Editor, – I read the dental note (Aust Prescr 2010;33:71) about not using amoxycillin as the first drug of choice for oral infection to reduce the prevalence of multiresistant bacteria, for example life-threateningStreptococcus pneumoniae.
I am a dentist and we have always been told that amoxycillin is the best and safest antimicrobial when encountering oral infection. So what will be the next best thing?
Associate Professor Michael McCullough, Chair, Therapeutics Committee, Australian Dental Association, comments:
It is true that for many years dentists were told that amoxycillin was the best and safest antibiotic for most dental infections. However, this idea has been considerably challenged over the past several decades and has led to the current concept that penicillin is the best choice as first option. These concepts are clearly outlined in the Therapeutic Guidelines: Oral and Dental.
Unfortunately, there is probably not going to be a 'next best thing', so we need to use our currently available antimicrobial medications judiciously.
Dentist, Tuggerah, NSW
Chair, Therapeutics Committee, Australian Dental Association